Loading Nifty 50, Nifty Bank, and Sensex…
Medicamen Biotech Limited
MEDICAMEQ · Corporate filings
NSE
Medicamen Biotech Limited
MEDICAMEQ · NSE · Healthcare
₹271.80
-1.33%
As of 12 Nov 2026
Medicamen Biotech Limited (MEDICAMEQ) is listed on NSE in the Healthcare sector. It last traded at ₹271.80, down 1.33% on the session. Its 52-week range is ₹212.40 to ₹447.65.
Research output is rule-based and informational only. It is not investment advice.
Analytics for MEDICAMEQ are not available yet. Technicals, fundamentals, peer ranking
and risk notes appear here once this listing's daily history and annual filings are synced.
Financial Charts & Report
Stock market charts for Medicamen Biotech Limited quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Results Change Summary quarter-on-quarter and year-on-year filing evidence
Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns stock, sector, and exchange benchmarks
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
Corporate Governance SEBI integrated governance filing
Loading governance disclosure...
Announcements
Announcement
Insider trading
Insider trading
Announcement
Surveillance
Price band change (next trade date)
Surveillance
Price band change (next trade date)
Surveillance
Price band change (next trade date)
Surveillance
Price band change (next trade date)
Announcement
Announcement
Announcement
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Full history
Dividend
Dividend - Re 1 Per Share Dividend - Re 1 Per Share
Ex-date: 18 Sep 2026
Dividend
Dividend - Re 1 Per Share Dividend - Re 1 Per Share
Ex-date: 19 Sep 2025
Dividend
Annual General Meeting/Dividend - Re 1 Per Share Annual General Meeting/Dividend - Re 1 Per Share
Ex-date: 19 Sep 2024
Dividend
Annual General Meeting/Dividend - Re 1 Per Share Annual General Meeting/Dividend - Re 1 Per Share
Ex-date: 20 Sep 2023
Dividend
Annual General Meeting/Dividend - Re 1 Per Share Annual General Meeting/Dividend - Re 1 Per Share
Ex-date: 19 Sep 2022
Board Meetings
14 Aug 2026
Medicamen Biotech Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
27 May 2026
Medicamen Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
13 Feb 2026
Medicamen Biotech Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
13 Feb 2026
Medicamen Biotech Limited has informed the Exchange regarding Board meeting held on February 13, 2026.
14 Nov 2025
Medicamen Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
12 Aug 2025
Medicamen Biotech Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
12 Aug 2025
Medicamen Biotech Limited has informed the Exchange regarding Board meeting held on August 12, 2025.
12 Aug 2025
Medicamen Biotech Limited has informed the Exchange regarding Board meeting held on August 12, 2025.